Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
53.9M
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
10.8M
-
Shares change
-
+920K
-
Total reported value, excl. options
-
$75.5M
-
Value change
-
+$5.31M
-
Number of buys
-
30
-
Number of sells
-
-6
-
Price
-
$7.00
Significant Holders of Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) as of Q2 2023
41 filings reported holding OBIO - Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share as of Q2 2023.
Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.8M shares
of 53.9M outstanding shares and own 19.99% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (5.62M shares), PERCEPTIVE ADVISORS LLC (2.05M shares), BlackRock Inc. (856K shares), PRICE T ROWE ASSOCIATES INC /MD/ (647K shares), Boxer Capital, LLC (250K shares), GEODE CAPITAL MANAGEMENT, LLC (195K shares), VANGUARD GROUP INC (192K shares), CITADEL ADVISORS LLC (170K shares), STATE STREET CORP (142K shares), and SVB Financial Group (127K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.